Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial

Authors: Katherine V. Houser, Grace L. Chen, Cristina Carter, Michelle C. Crank, Thuy A. Nguyen, Maria Claudia Burgos Florez, Nina M. Berkowitz, Floreliz Mendoza, Cynthia Starr Hendel, Ingelise J. Gordon, Emily E. Coates, Sandra Vazquez, Judy Stein, Christopher L. Case, Heather Lawlor, Kevin Carlton, Martin R. Gaudinski, Larisa Strom, Amelia R. Hofstetter, C. Jason Liang, Sandeep Narpala, Christian Hatcher, Rebecca A. Gillespie, Adrian Creanga, Masaru Kanekiyo, Julie E. Raab, Sarah F. Andrews, Yi Zhang, Eun Sung Yang, Lingshu Wang, Kwanyee Leung, Wing-Pui Kong, Alec W. Freyn, Raffael Nachbagauer, Peter Palese, Robert T. Bailer, Adrian B. McDermott, Richard A. Koup, Jason G. Gall, Frank Arnold, John R. Mascola, Barney S. Graham, Julie E. Ledgerwood, , Joseph Casazza, Lasonji Holman, Abidemi O. Ola, Pamela Costner, Jennifer Cunningham, Brenda Larkin, Laura Novik, Jamie Saunders, William Whalen, Xiaolin Wang, Aba Mensima Eshun, Alison Taylor, K. C. Cheng, Carolyn Laurencot, Josephine H. Cox, Sandra Sitar, Lam Le, Iris Pittman, Olga Vasilenko, Ro Shauna Rothwell, Galina Yamshchikov, Eugenia Burch, Somia Hickman, Olga Trofymenko, Catina Boyd, Preeti Apte, Cora Trelles Cartagena, Renunda Hicks, Pernell Williams, Zana Blaku, Colin Tran

Published: 2022-02-03

DOI: 10.1038/s41591-021-01660-8

Source: Full article


Abstract

No abstract found.